Baillie Gifford European Growth Trust Reports Challenging H1 Amid Strategic Tender Offer
Baillie Gifford European Growth Trust's H1 NAV fell 6.7% vs +3.5% benchmark. 2028 tender offer & 8.6% discount hint at rebound potential. Insights here.
This article covers information on Baillie Gifford European Growth Tst.
LON:BGEURough Seas in European Growth Waters
Baillie Gifford European Growth Trust’s first-half report reads like a thriller novel where the protagonist spends 200 pages getting punched in the face. A -6.7% NAV tumble against a +3.5% benchmark rise? Ouch. But as any seasoned investor knows, it’s the third act redemption arc that matters – and this trust is betting big on a comeback story.
The Numbers That Matter
- NAV Total Return: -6.7% (Benchmark: +3.5%)
- Assets Under Management: £378.1m (-9% since Sept 2024)
- Discount Narrowing: 15.6% → 8.6% (Thank £9.6m in buybacks)
- Trump Tariff Tango: 15% US sales exposure vs 22% benchmark
Portfolio Pain Points & Bright Spots
The ‘Three Horsemen of Underperformance’ – Hypoport (German mortgages), Nexans (wind cables), and Soitec (silicon wafers) – are all caught in cyclical crosswinds. Yet managers argue these are operational stalwarts simply waiting for macroeconomic winds to shift.
The Italian Stallion
Enter Bending Spoons – the Milanese software house quietly building an empire of AI-powered apps. This 4.5% private holding (+£17m valuation) exemplifies Baillie Gifford’s conviction: “Profitable, asset-light, and about as competitive as Messi in a pub league.”
Strategic Chess Moves
While selling six positions (including CRISPR Therapeutics’ gene-editing gambles), the team placed three intriguing bets:
- ASM International: The ‘other’ Dutch chip play – think atomic layer deposition, not ASML’s lithography
- Edenred: Meal voucher maestro trading at 2010 valuations after Brazil scare
- Röko: Swedish acquisition roll-up with Lifco’s playbook and 5x growth runway
The £327m Question: To Tender or Not?
That looming 2028 performance-linked tender offer adds spice to the narrative. Fail to beat the benchmark, and shareholders get an exit near NAV. It’s a bold move that says: “We’ll put skin in the game, but European growth stocks need time to marinate.”
Silver Linings Playbook
Despite the storm clouds, three rays of sunlight pierce through:
- European GDP catching up to US (Germany’s green/defence spending surge)
- Tech platforms like Spotify demonstrating pricing power amidst tariff chaos
- Structural growth stories in semiconductors, biologics, and building materials
Bottom Line for Investors
This isn’t a ‘set and forget’ trust. The -8.6% discount whispers opportunity, but requires conviction in:
- Europe’s rearmament/energy transition creating new champions
- Growth-style resurgence after value’s recent dominance
- Baillie Gifford’s stock-picking chops to justify 0.55% fees
As Chairman Barron diplomatically notes: “You make most of your money in bear markets – you just don’t realise it at the time.” Whether this proves prescient or Pollyannaish depends on Europe’s ability to dance through the Trumpian trade war minefield. One to watch with both optimism and a tightly set stop-loss.
Related
Keep reading
Investing
Brave Bison Raises System1 Offer to £47.5 Million as Delisting Stakes Grow
Brave Bison's fourth System1 offer values the target at £47.5 million, but the deal remains conditional on securing majority support.
JoshuaSeptember 14, 2026
Investing
Keras Resources pivots to Namibian copper with US phosphate sale and £1.7 million raise
Keras Resources is reshaping itself around Namibian copper, backed by a US phosphate disposal, royalties and a £1.7 million raise.
JoshuaSeptember 14, 2026
Investing
Empyrean Energy adds Austrian gas exposure as equity fundraising looms
Empyrean Energy has agreed an Austrian gas farm-in, but shareholders face exploration risk, a trading halt and likely equity dilution.
JoshuaSeptember 14, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.